SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR410 in human neuroblastoma cells

Jerusha Boyineni, Smita Tanpure, Manu Gnanamony, Reuben Antony, Karen S. Fern�ndez, Julian Lin, David Pinson, Christopher S. Gondi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Neuroblastoma (NB) is the most common extracranial solid tumor in children and despite aggressive therapy survival rates remain low. One of the contributing factors for low survival rates is aggressive tumor angiogenesis, which is known to increase due to radiation, one of the standard therapies for neuroblastoma. Therefore, targeting tumor angiogenesis can be a viable add-on therapy for the treatment of neuroblastomas. In the present study, we demonstrate that overexpression of secreted protein acidic and rich in cysteine (SPARC) suppresses radiation induced angiogenesis in SK-NBE(2) and NB1691 neuroblastoma cells. We observed that overexpression of SPARC in SK-N-BE(2) and NB1691 cells reduced radiation induced angiogenesis in an in vivo mouse dorsal skin model and an ex vivo chicken CAM (chorioallantoic-membrane) model and also reduced tumor size in subcutaneous mouse tumor models of NB. We also observed that SPARC overexpression reduces VEGF-A expression, in SK-N-BE(2) and NB1691 NB cells via miR-410, a VEGF-A targeting microRNA. SPARC overexpression alone or in combination with miR-410 and radiation was shown to be effective at reducing angiogenesis. Moreover, addition of miR-410 inhibitors reversed SPARC mediated inhibition of VEGF-A in NB1691 cells but not in SK-N-BE(2) NB cells. In conclusion, the present study demonstrates that the overexpression of SPARC in combination with radiation reduced tumor angiogenesis by downregulating VEGF-A via miR-410.

Original languageEnglish (US)
Pages (from-to)1394-1406
Number of pages13
JournalInternational Journal of Oncology
Volume49
Issue number4
DOIs
StatePublished - Oct 1 2016
Externally publishedYes

Fingerprint

Neuroblastoma
Vascular Endothelial Growth Factor A
Cysteine
Radiation
Proteins
Neoplasms
Chorioallantoic Membrane
Therapeutics
MicroRNAs
Chickens
Down-Regulation
Skin

Keywords

  • Angiogenesis
  • CAM chorioallantoic-membrane
  • Neuroblastoma
  • Radiation miR-410
  • SPARC
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR410 in human neuroblastoma cells. / Boyineni, Jerusha; Tanpure, Smita; Gnanamony, Manu; Antony, Reuben; Fern�ndez, Karen S.; Lin, Julian; Pinson, David; Gondi, Christopher S.

In: International Journal of Oncology, Vol. 49, No. 4, 01.10.2016, p. 1394-1406.

Research output: Contribution to journalArticle

Boyineni, Jerusha ; Tanpure, Smita ; Gnanamony, Manu ; Antony, Reuben ; Fern�ndez, Karen S. ; Lin, Julian ; Pinson, David ; Gondi, Christopher S. / SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR410 in human neuroblastoma cells. In: International Journal of Oncology. 2016 ; Vol. 49, No. 4. pp. 1394-1406.
@article{7ecc2361901841bd97d523d9c53cefbb,
title = "SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR410 in human neuroblastoma cells",
abstract = "Neuroblastoma (NB) is the most common extracranial solid tumor in children and despite aggressive therapy survival rates remain low. One of the contributing factors for low survival rates is aggressive tumor angiogenesis, which is known to increase due to radiation, one of the standard therapies for neuroblastoma. Therefore, targeting tumor angiogenesis can be a viable add-on therapy for the treatment of neuroblastomas. In the present study, we demonstrate that overexpression of secreted protein acidic and rich in cysteine (SPARC) suppresses radiation induced angiogenesis in SK-NBE(2) and NB1691 neuroblastoma cells. We observed that overexpression of SPARC in SK-N-BE(2) and NB1691 cells reduced radiation induced angiogenesis in an in vivo mouse dorsal skin model and an ex vivo chicken CAM (chorioallantoic-membrane) model and also reduced tumor size in subcutaneous mouse tumor models of NB. We also observed that SPARC overexpression reduces VEGF-A expression, in SK-N-BE(2) and NB1691 NB cells via miR-410, a VEGF-A targeting microRNA. SPARC overexpression alone or in combination with miR-410 and radiation was shown to be effective at reducing angiogenesis. Moreover, addition of miR-410 inhibitors reversed SPARC mediated inhibition of VEGF-A in NB1691 cells but not in SK-N-BE(2) NB cells. In conclusion, the present study demonstrates that the overexpression of SPARC in combination with radiation reduced tumor angiogenesis by downregulating VEGF-A via miR-410.",
keywords = "Angiogenesis, CAM chorioallantoic-membrane, Neuroblastoma, Radiation miR-410, SPARC, Vascular endothelial growth factor",
author = "Jerusha Boyineni and Smita Tanpure and Manu Gnanamony and Reuben Antony and Fern{\"i}¿½ndez, {Karen S.} and Julian Lin and David Pinson and Gondi, {Christopher S.}",
year = "2016",
month = "10",
day = "1",
doi = "10.3892/ijo.2016.3646",
language = "English (US)",
volume = "49",
pages = "1394--1406",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR410 in human neuroblastoma cells

AU - Boyineni, Jerusha

AU - Tanpure, Smita

AU - Gnanamony, Manu

AU - Antony, Reuben

AU - Fern�ndez, Karen S.

AU - Lin, Julian

AU - Pinson, David

AU - Gondi, Christopher S.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Neuroblastoma (NB) is the most common extracranial solid tumor in children and despite aggressive therapy survival rates remain low. One of the contributing factors for low survival rates is aggressive tumor angiogenesis, which is known to increase due to radiation, one of the standard therapies for neuroblastoma. Therefore, targeting tumor angiogenesis can be a viable add-on therapy for the treatment of neuroblastomas. In the present study, we demonstrate that overexpression of secreted protein acidic and rich in cysteine (SPARC) suppresses radiation induced angiogenesis in SK-NBE(2) and NB1691 neuroblastoma cells. We observed that overexpression of SPARC in SK-N-BE(2) and NB1691 cells reduced radiation induced angiogenesis in an in vivo mouse dorsal skin model and an ex vivo chicken CAM (chorioallantoic-membrane) model and also reduced tumor size in subcutaneous mouse tumor models of NB. We also observed that SPARC overexpression reduces VEGF-A expression, in SK-N-BE(2) and NB1691 NB cells via miR-410, a VEGF-A targeting microRNA. SPARC overexpression alone or in combination with miR-410 and radiation was shown to be effective at reducing angiogenesis. Moreover, addition of miR-410 inhibitors reversed SPARC mediated inhibition of VEGF-A in NB1691 cells but not in SK-N-BE(2) NB cells. In conclusion, the present study demonstrates that the overexpression of SPARC in combination with radiation reduced tumor angiogenesis by downregulating VEGF-A via miR-410.

AB - Neuroblastoma (NB) is the most common extracranial solid tumor in children and despite aggressive therapy survival rates remain low. One of the contributing factors for low survival rates is aggressive tumor angiogenesis, which is known to increase due to radiation, one of the standard therapies for neuroblastoma. Therefore, targeting tumor angiogenesis can be a viable add-on therapy for the treatment of neuroblastomas. In the present study, we demonstrate that overexpression of secreted protein acidic and rich in cysteine (SPARC) suppresses radiation induced angiogenesis in SK-NBE(2) and NB1691 neuroblastoma cells. We observed that overexpression of SPARC in SK-N-BE(2) and NB1691 cells reduced radiation induced angiogenesis in an in vivo mouse dorsal skin model and an ex vivo chicken CAM (chorioallantoic-membrane) model and also reduced tumor size in subcutaneous mouse tumor models of NB. We also observed that SPARC overexpression reduces VEGF-A expression, in SK-N-BE(2) and NB1691 NB cells via miR-410, a VEGF-A targeting microRNA. SPARC overexpression alone or in combination with miR-410 and radiation was shown to be effective at reducing angiogenesis. Moreover, addition of miR-410 inhibitors reversed SPARC mediated inhibition of VEGF-A in NB1691 cells but not in SK-N-BE(2) NB cells. In conclusion, the present study demonstrates that the overexpression of SPARC in combination with radiation reduced tumor angiogenesis by downregulating VEGF-A via miR-410.

KW - Angiogenesis

KW - CAM chorioallantoic-membrane

KW - Neuroblastoma

KW - Radiation miR-410

KW - SPARC

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84990028160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990028160&partnerID=8YFLogxK

U2 - 10.3892/ijo.2016.3646

DO - 10.3892/ijo.2016.3646

M3 - Article

C2 - 27498840

AN - SCOPUS:84990028160

VL - 49

SP - 1394

EP - 1406

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 4

ER -